Growth Metrics

Microbot Medical (MBOT) EBIT (2016)

Historic EBIT for Microbot Medical (MBOT) over the last 7 years, with Q3 2016 value amounting to -$1.9 million.

  • Microbot Medical's EBIT rose 8117.86% to -$1.9 million in Q3 2016 from the same period last year, while for Sep 2016 it was -$29.1 million, marking a year-over-year increase of 2338.02%. This contributed to the annual value of -$9.1 million for FY2020, which is 2553.87% down from last year.
  • Per Microbot Medical's latest filing, its EBIT stood at -$1.9 million for Q3 2016, which was up 8117.86% from -$8.9 million recorded in Q2 2016.
  • Microbot Medical's EBIT's 5-year high stood at -$1.9 million during Q3 2016, with a 5-year trough of -$10.0 million in Q3 2015.
  • Over the past 5 years, Microbot Medical's median EBIT value was -$6.8 million (recorded in 2014), while the average stood at -$7.3 million.
  • Per our database at Business Quant, Microbot Medical's EBIT plummeted by 5656.09% in 2015 and then soared by 8117.86% in 2016.
  • Quarter analysis of 5 years shows Microbot Medical's EBIT stood at -$6.2 million in 2012, then tumbled by 45.53% to -$9.0 million in 2013, then decreased by 8.61% to -$9.7 million in 2014, then increased by 12.64% to -$8.5 million in 2015, then skyrocketed by 77.88% to -$1.9 million in 2016.
  • Its EBIT was -$1.9 million in Q3 2016, compared to -$8.9 million in Q2 2016 and -$9.8 million in Q1 2016.